NEX-I, Inc.
PrivateLast Round
Private Equity
May 15, 2026
Est. Valuation
$127.4M
Total Funding Raised
$101.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NEX-I, Inc. is a biotechnology company that develops next-generation immunotherapeutics to overcome resistance to cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEX-I, Inc. Comparables
Compare NEX-I, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Compugen Ltd. | 77% | |
| MedPacto, Inc. | 74% | |
| Pinotbio | 73% |
NEX-I, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 15, 2026 | ||||
| Series B | Aug 12, 2025 | ||||
| Series A | Oct 7, 2022 | ||||
| Pre Seed | Dec 22, 2021 |
NEX-I, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hana Ventures | Pre Seed, Private Equity, Series A, Series B |
| InterVest | Private Equity |
| DSC Investment | Pre Seed, Private Equity, Series B, Series A |
| K2 Investment Partners | Private Equity, Series B |
| KB Investment | Private Equity, Series B |
| TS Investment | Private Equity, Series A, Series B |
| DS Asset Management | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
$34M round with participation from K2 Investment Partners and Wonik Investment Partners.
- Aug 12, 2025
$44M round with participation from CJ Investment and IBK.
NEX-I, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NEX-I, Inc.'s valuation, stock price, and market status.
Is NEX-I, Inc. a public or private company?
NEX-I, Inc. is a private company.
What is the current stock price of NEX-I, Inc.?
NEX-I, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is NEX-I, Inc. worth (valuation)?
NEX-I, Inc.'s valuation is estimated at $43.3M based on funding round data.
Can I buy NEX-I, Inc. stock?
NEX-I, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NEX-I, Inc.'s last funding round?
NEX-I, Inc.'s most recent funding round was Series B on October 7, 2022.
Who are the main investors in NEX-I, Inc.?
Key investors in NEX-I, Inc. include DSC Investment.
Will NEX-I, Inc. IPO soon?
No public IPO plans have been announced for NEX-I, Inc..
How can I track NEX-I, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NEX-I, Inc.'s secondary market activity and sign up for updates.